Items where Author is "Soderberg, S."
 | Up a level |
Conference or Workshop Item
Soderberg, S. and Gaine, S. and Muller, A. and Klement, R. and Lange, T. and Escribano, P. (2022) Characterisation of pulmonary arterial hypertension patients with cardiovascular comorbidities treated with selexipag: real-world evidence from the EXPOSURE study. In: ESC Congress 2022, 26. - 29. August 2022, Barcelona, Spain.
Escribano, P. and Gaine, S. and Klement, R. and Muller, A. and Lange, T. J. and Soderberg, S. (2022) Pulmonary arterial hypertension associated with congenital heart disease: real-world analysis of clinical characteristics, treatment patterns and outcomes from EXPOSURE. In: ESC Congress 2022, 26. - 29. August 2022, Barcelona, Spain.
Escribano, P. and Gaine, S. and Biedermann, P. and Muller, A. and Valge, M. and Lange, T. and Soderberg, S. (2021) Characterisation of Pulmonary Arterial Hypertension (PAH) Patients Initiating a New PAH Specific Therapy in the Context of Age: Insights from EXPOSURE. In: 41st Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT), APR 24 - 28, 2021, Toronto, Canada, hybrid.
Other
Muller, A. and Soderberg, S. and Escribano, P. and Biedermann, P. and Sun, H. and Lange, T. J. and Gaine, S. (2019) REAL-WORLD USE OF SELEXIPAG AND OTHER PULMONARY ARTERIAL HYPERTENSION (PAH) THERAPIES: AN OBSERVATIONAL COHORT STUDY IN PATIENTS WITH PAH (EXPOSURE). ELSEVIER SCIENCE INC, NEW YORK.
